Table of Contents
1 Research Objective
Objective of the study
1.1 Product Overview
1.2 Market Scope
1.3 Analysis Period of the Study
1.4 Data Reporting Unit
1.5 Key Stakeholders
2 Research Methodology
2.1 Research Methodology
2.2 Regional Split of Primary & Secondary Research
2.3 Secondary Research
2.4 Primary Research
2.4.1 Breakdown of Primary Research Respondents, By Industry Participants
2.5 Market Size Estimation
2.6 Assumptions for the Study
3 India Active Pharmaceutical Ingredients (API) Market Overview
3.1 India Active Pharmaceutical Ingredients (API) Market Size & Forecast
3.2 India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Manufacturing Process
3.3 India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Type of Synthesis
3.4 India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By API Formulation
3.5 India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Application
3.6 India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Region
4 West India Active Pharmaceutical Ingredients (API) Market Overview
4.1 West India Active Pharmaceutical Ingredients (API) Market Size & Forecast
4.2 West India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Manufacturing Process
4.3 West India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Type of Synthesis
4.4 West India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By API Formulation
4.5 West India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Application
5 North India Active Pharmaceutical Ingredients (API) Market Overview
5.1 North India Active Pharmaceutical Ingredients (API) Market Size & Forecast
5.2 North India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Manufacturing Process
5.3 North India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Type of Synthesis
5.4 North India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By API Formulation
5.5 North India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Application
6 South India Active Pharmaceutical Ingredients (API) Market Overview
6.1 South India Active Pharmaceutical Ingredients (API) Market Size & Forecast
6.2 South India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Manufacturing Process
6.3 South India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Type of Synthesis
6.4 South India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By API Formulation
6.5 South India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Application
7 East India Active Pharmaceutical Ingredients (API) Market Overview
7.1 East India Active Pharmaceutical Ingredients (API) Market Size & Forecast
7.2 East India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Manufacturing Process
7.3 East India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Type of Synthesis
7.4 East India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By API Formulation
7.5 East India Active Pharmaceutical Ingredients (API) Market Size & Share Forecast, By Application
8 Market Dynamics
8.1 Drivers
8.1.1 Rising prevalence of chronic diseases
8.1.2 Rising acceptance of artificial intelligence-based tools for drug discovery
8.1.3 Rising generics and biosimilars market
8.2 Limitations
8.2.1 Increasing Penetration of Counterfeit Drugs
8.3 Opportunities
8.3.1 Rising focus on precision medicine market
8.3.2 Increasing preference for outsourcing API’s
8.4 Technology Landscape and Innovation
8.5 Regulatory Framework
8.5.1 April 1940: Drugs and Cosmetics Act
8.5.2 March 1948: The Pharmacy Act
8.5.3 1986: Research and Development Cess Act
8.5.4 2002: Pharmaceutical Policy
8.5.5 Role of Government towards API
8.5.6 List of APIs Products Identified
8.6 Competitor & Product Analysis
8.7 Industry SWOT Analysis
8.8 Investment Analysis
8.9 Covid-19 Impact on India Active Pharmaceutical Ingredients (API) Market
8.10 Economic Impact on India Active Pharmaceutical Ingredients (API) Market
8.11 Company Share Analysis
8.12 Porter’s Five Forces Analysis
8.13 PESTEL Analysis
9 Competitive Landscape
9.1 Company Profiles
9.1.1 Dr. Reddy's Laboratories Ltd.
9.1.1.1 Business Overview
9.1.1.2 Key Products
9.1.1.3 Financial Metrics (USD Million)
9.1.1.4 Revenue by Segmentation
9.1.1.5 Revenue by Geography
9.1.1.6 Strategic Outlook
9.1.1.7 Key Personnel
9.1.1.8 Key Contact Person
9.1.1.9 SWOT Analysis
9.1.2 Aurobindo Pharma Limited
9.1.2.1 Business Overview
9.1.2.2 Key Products
9.1.2.3 Financial Metrics (USD Million)
9.1.2.4 Revenue by Segmentation
9.1.2.5 Revenue by Region
9.1.2.6 Strategic Outlook
9.1.2.7 Key Personnel
9.1.2.8 Key Contact Person
9.1.2.9 SWOT Analysis
9.1.3 Cipla Limited
9.1.3.1 Business Overview
9.1.3.2 Key Products
9.1.3.3 Financial Metrics (USD Million)
9.1.3.4 Revenue by Segmentation
9.1.3.5 Revenue of API by Geography
9.1.3.6 Key Personnel
9.1.3.7 Key Contact Person
9.1.3.8 Strategic Outlook
9.1.3.9 SWOT Analysis
9.1.4 Sun Pharmaceutical Industries Limited
9.1.4.1 Business Overview
9.1.4.2 Key Products
9.1.4.3 Financial Metrics (USD Million)
9.1.4.4 Revenue by Geography
9.1.4.5 Revenue by Segment
9.1.4.6 Strategic Outlook
9.1.4.7 Key Personnel
9.1.4.8 Key Contact Person
9.1.4.9 SWOT Analysis
9.1.5 GlaxoSmithKline Pharmaceuticals Ltd
9.1.5.1 Business Overview
9.1.5.2 Key Products
9.1.5.3 Financial Metrices (USD Million)
9.1.5.4 Strategic Outlook
9.1.5.5 Key Personnel
9.1.5.6 Key Contact Person
9.1.5.7 SWOT Analysis
9.1.6 Indoco Remedies Ltd.
9.1.6.1 Business Overview
9.1.6.2 Key Products
9.1.6.3 Financial Metrices (USD Million)
9.1.6.4 Revenue by Geography
9.1.6.5 Strategic Outlook
9.1.6.6 Key Personnel
9.1.6.7 Key Contact Person
9.1.6.8 SWOT Analysis
9.1.7 Piramal Enterprises Ltd.
9.1.7.1 Business Overview
9.1.7.2 Key Products
9.1.7.3 Financial Metrices (USD Million)
9.1.7.4 Revenue by Segmentation of Pharma
9.1.7.5 Revenue of Pharma by Geography
9.1.7.6 Strategic Outlook
9.1.7.7 Key Personnel
9.1.7.8 Key Contact Person
9.1.7.9 SWOT Analysis
9.1.8 Teva Pharmaceutical & Chemical Industries India Pvt. Ltd.
9.1.8.1 Business Overview
9.1.8.2 Key Products
9.1.8.3 Key Personnel
9.1.8.4 Key Contact Person
9.1.8.5 SWOT Analysis
9.1.9 Sri Krishna Pharmaceuticals Limited
9.1.9.1 Business Overview
9.1.9.2 Key Products
9.1.9.3 Financial Metrices (USD Million)
9.1.9.4 Key Personnel
9.1.9.5 Key Contact Person
9.1.9.6 SWOT Analysis
9.1.10 Pan Drugs Limited
9.1.10.1 Business Overview
9.1.10.2 Key Products
9.1.10.3 Key Personnel
9.1.10.4 Key Contact Person
9.1.10.5 SWOT Analysis
List of Figures
FIGURE 1 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SEGMENTATION
FIGURE 2 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) VALUE ($) AND GROWTH RATE FROM 2016-2027
FIGURE 3 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY MANUFACTURING PROCESS 2016-2027
FIGURE 4 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY TYPE OF SYNTHESIS 2016-2027
FIGURE 5 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY API FORMULATION 2016-2027
FIGURE 6 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY APPLICATION 2016-2027
FIGURE 7 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY REGION 2016-2027
FIGURE 8 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) VALUE ($) AND GROWTH RATE FROM 2016-2027
FIGURE 9 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY MANUFACTURING PROCESS 2016-2027
FIGURE 10 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY TYPE OF SYNTHESIS 2016-2027
FIGURE 11 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY API FORMULATION 2016-2027
FIGURE 12 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY APPLICATION 2016-2027
FIGURE 13 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) VALUE ($) AND GROWTH RATE FROM 2016-2027
FIGURE 14 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY MANUFACTURING PROCESS 2016-2027
FIGURE 15 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY TYPE OF SYNTHESIS 2016-2027
FIGURE 16 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY API FORMULATION 2016-2027
FIGURE 17 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY APPLICATION 2016-2027
FIGURE 18 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) VALUE ($) AND GROWTH RATE FROM 2016-2027
FIGURE 19 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY MANUFACTURING PROCESS 2016-2027
FIGURE 20 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY TYPE OF SYNTHESIS 2016-2027
FIGURE 21 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY API FORMULATION 2016-2027
FIGURE 22 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY APPLICATION 2016-2027
FIGURE 23 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) VALUE ($) AND GROWTH RATE FROM 2016-2027
FIGURE 24 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY MANUFACTURING PROCESS 2016-2027
FIGURE 25 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY TYPE OF SYNTHESIS 2016-2027
FIGURE 26 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY API FORMULATION 2016-2027
FIGURE 27 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SHARE, BY APPLICATION 2016-2027
FIGURE 28 TOTAL DEATH BY CHRONIC DISEASE IN INDIA
FIGURE 29 IOT DEVICES IN INDIA (USD BILLION)
FIGURE 30 INDIA API MARKET, COMPANY SHARES 2019
List of Table
TABLE 1 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY MANUFACTURING PROCESS 2016-2027
TABLE 2 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY TYPE OF SYNTHESIS 2016-2027
TABLE 3 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY API FORMULATION 2016-2027
TABLE 4 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY APPLICATION 2016-2027
TABLE 5 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY REGION 2016-2027
TABLE 6 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY MANUFACTURING PROCESS 2016-2027
TABLE 7 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY TYPE OF SYNTHESIS 2016-2027
TABLE 8 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY API FORMULATION 2016-2027
TABLE 9 WEST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY APPLICATION 2016-2027
TABLE 10 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY MANUFACTURING PROCESS 2016-2027
TABLE 11 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY TYPE OF SYNTHESIS 2016-2027
TABLE 12 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY API FORMULATION 2016-2027
TABLE 13 NORTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY APPLICATION 2016-2027
TABLE 14 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY MANUFACTURING PROCESS 2016-2027
TABLE 15 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY TYPE OF SYNTHESIS 2016-2027
TABLE 16 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY API FORMULATION 2016-2027
TABLE 17 SOUTH INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY APPLICATION 2016-2027
TABLE 18 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY MANUFACTURING PROCESS 2016-2027
TABLE 19 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY TYPE OF SYNTHESIS 2016-2027
TABLE 20 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY API FORMULATION 2016-2027
TABLE 21 EAST INDIA ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET SIZE, BY APPLICATION 2016-2027
TABLE 22 DR. REDDY'S LABORATORIES LTD. – AT A GLANCE
TABLE 23 AUROBINDO PHARMA LIMITED – AT A GLANCE
TABLE 24 CIPLA LIMITED. – AT A GLANCE
TABLE 25 SUN PHARMACEUTICAL INDUSTRIES LIMITED – AT A GLANCE
TABLE 26 GLAXOSMITHKLINE PHARMACEUTICALS LTD – AT A GLANCE
TABLE 27 INDOCO REMEDIES LTD. – AT A GLANCE
TABLE 28 PIRAMAL ENTERPRISES LTD. – AT A GLANCE
TABLE 29 TEVA PHARMACEUTICAL & CHEMICAL INDUSTRIES INDIA PVT. LTD. - AT A GLANCE TABLE 30 SRI KRISHNA PHARMACEUTICALS LIMITED. – AT A GLANCE
TABLE 31 PAN DRUGS LIMITED– AT A GLANCE